SanBio Co Ltd (SNBIF)
3.85
0.00 (0.00%)
USD |
OTCM |
Nov 15, 16:00
SanBio Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2020 | 0.2097M |
| October 31, 2019 | -0.0319M |
| July 31, 2019 | 2.192M |
| April 30, 2019 | 1.706M |
| January 31, 2019 | 1.550M |
| October 31, 2018 | 1.370M |
| July 31, 2018 | 2.329M |
| April 30, 2018 | 1.478M |
| January 31, 2018 | 1.062M |
| October 31, 2017 | 1.091M |
| July 31, 2017 | 1.127M |
| Date | Value |
|---|---|
| April 30, 2017 | 1.105M |
| January 31, 2017 | 1.692M |
| October 31, 2016 | 0.7205M |
| July 31, 2016 | 0.5531M |
| April 30, 2016 | 5.557M |
| January 31, 2016 | 0.622M |
| October 31, 2015 | 5.683M |
| July 31, 2015 | 1.032M |
| April 30, 2015 | 2.382M |
| January 31, 2015 | 0.9243M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.2097M
Minimum
Jan 2020
0.2097M
Maximum
Jan 2020
0.2097M
Average
0.2097M
Median
Jan 2020
Revenue (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 7.918B |
| Nxera Pharma Co Ltd | 62.36M |
| PeptiDream Inc | 204.69M |
| Healios KK | 3.195M |
| AnGes Inc | 0.8352M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.409M |
| Total Expenses (Quarterly) | 5.761M |
| EPS Diluted (Quarterly) | -0.108 |
| Enterprise Value | 247.52M |
| Earnings Yield | -5.47% |
| Normalized Earnings Yield | -24.04 |